Association of early recanalization with reperfusion and clinical outcome following intravenous tPA at 3 to 6 hours: Results of the DEFUSE study

被引:0
|
作者
Marks, MP
Thijs, VN
Kakuda, W
Wechsler, L
Bammer, R
Kemp, S
Albers, GW
机构
[1] Stanford Stroke Ctr, Palo Alto, CA USA
[2] UZ Gasthuisberg, Louvain, Belgium
[3] Univ Pittsburgh, Pittsburgh, PA USA
关键词
D O I
暂无
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
引用
收藏
页码:635 / 635
页数:1
相关论文
共 20 条
  • [1] Recanalization Leads To Early Clinical Improvement In Patients Treated With Argatroban And Intravenous TPA A Subanalysis Of The Argatroban Tpa Stroke Study
    Guerrero, Waldo R.
    Alexandrov, Andrei V.
    Lyden, Pat
    Alderazi, Yazan
    Lee, Jessica Lee
    Martin-Schild, Sheryl
    Shen, Loren
    Sisson, April
    Balucani, Clotilde
    Peng, Hui
    Savitz, Sean I.
    Gonzales, Nicole R.
    Wu, Tzu-Ching
    Rahbar, Mohammad H.
    Tsivgoulis, Georgios
    Demchuk, Andrew M.
    Grotta, James C.
    Barreto, Andrew D.
    STROKE, 2013, 44 (02)
  • [2] Optimal outcome measures for detecting clinical benefits of early reperfusion: Insights from the DEFUSE study.
    Kakuda, Wataru
    Hamilton, Scott
    Thijs, Vincent N.
    Lansberg, Maarten G.
    Kemp, Stephanie
    Skalabrin, Elaine
    Albers, Gregory W.
    STROKE, 2008, 39 (02) : 694 - 694
  • [3] Reperfusion within 6 hours outperforms recanalization in predicting penumbra salvage, lesion growth, final infarct and clinical outcome
    Cho, T. H.
    Nighoghossian, N.
    Mikkelsen, I. K.
    Derex, L.
    Hennier, M.
    Pedraza, S.
    Fiehler, J.
    Ostergaard, L.
    Berthezene, Y.
    Baron, J. C.
    CEREBROVASCULAR DISEASES, 2015, 39 : 100 - 100
  • [4] Reperfusion Within 6 Hours Outperforms Recanalization in Predicting Penumbra Salvage, Lesion Growth, Final Infarct, and Clinical Outcome
    Cho, Tae-Hee
    Nighoghossian, Norbert
    Mikkelsen, Irene Klaerke
    Derex, Laurent
    Hermier, Marc
    Pedraza, Salvador
    Fiehler, Jens
    Ostergaard, Leif
    Berthezene, Yves
    Baron, Jean-Claude
    STROKE, 2015, 46 (06) : 1582 - +
  • [5] Patients with Acute Stroke Treated with Intravenous tPA 3-6 Hours after Stroke Onset: Correlations between MR Angiography Findings and Perfusion- and Diffusion-weighted Imaging in the DEFUSE Study
    Marks, Michael P.
    Olivot, Jean-Marc
    Kemp, Stephanie
    Lansberg, Maarten G.
    Bammer, Roland
    Wechsler, Lawrence R.
    Albers, Gregory W.
    Thijs, Vincent
    RADIOLOGY, 2008, 249 (02) : 614 - 623
  • [6] Do early CT changes predict clinical outcome following administration of intravenous R-Tpa for acute ischemic stroke?
    Luire, DN
    Mendizabal, JE
    Greiner, FG
    Zweifler, RM
    STROKE, 2000, 31 (01) : 276 - 276
  • [7] TNK induces faster MCA recanalization and leads to better short- and long-term clinical outcome than native tPA. The TNK-TPA reperfusion stroke study
    Molina, Carlos A.
    Ribo, Marc
    Rubiera, Marta
    Santamarina, Estevo
    Delgado-Mederos, Raquel
    Maisterra, Olga
    Delgado, Pilar
    Dinia, Lavinia
    Pontes, Octavio
    Montaner, Joan
    Alvarez-Sabin, Jose
    STROKE, 2008, 39 (02) : 563 - 563
  • [8] Comparison of intravenous and intra-arterial with tPA within 3-6 hours guided by Multi-MRI: Randomised study of 36 patients
    Wang, Yilong
    Jiang, Weijian
    Liao, Xiaoling
    Du, Bin
    Zhao, Xingquan
    Dong, Kehui
    Xue, Jing
    Gao, Peiyi
    Liu, Liping
    Wang, Yongjun
    STROKE, 2008, 39 (02) : 602 - 602
  • [9] Intravenous busulfan in children prior to stem cell transplantation: study of pharmacokinetics in association with early clinical outcome and toxicity
    Zwaveling, J
    Bredius, RGM
    Cremers, SCLM
    Ball, LM
    Lankester, AC
    Teepe-Twiss, IM
    Egeler, RM
    den Hartigh, J
    Vossen, JM
    BONE MARROW TRANSPLANTATION, 2005, 35 (01) : 17 - 23
  • [10] Intravenous busulfan in children prior to stem cell transplantation: study of pharmacokinetics in association with early clinical outcome and toxicity
    J Zwaveling
    R G M Bredius
    S C L M Cremers
    L M Ball
    A C Lankester
    I M Teepe-Twiss
    R M Egeler
    J den Hartigh
    J M Vossen
    Bone Marrow Transplantation, 2005, 35 : 17 - 23